We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$768M
AUM Growth
+$22.1M
Cap. Flow
+$2.91M
Cap. Flow %
0.38%
Top 10 Hldgs %
32.63%
Holding
159
New
5
Increased
19
Reduced
83
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Technology 22.56%
3 Industrials 18.94%
4 Utilities 17.38%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKH icon
26
Black Hills Corp
BKH
$5.42B
$10.7M 1.39%
162,500
-1,800
-1% -$122K
LNN icon
27
Lindsay Corp
LNN
$1.13B
$10.6M 1.39%
64,325
-2,800
-4% -$461K
TSM icon
28
TSMC
TSM
$2.1T
$10.5M 1.37%
87,202
-867
-1% -$102K
MSFT icon
29
Microsoft
MSFT
$3.45T
$10.5M 1.36%
38,620
-1,000
-3% -$254K
TEL icon
30
TE Connectivity
TEL
$59.6B
$10.4M 1.35%
76,584
-1,000
-1% -$134K
SLB icon
31
SLB Ltd
SLB
$73.6B
$9.96M 1.3%
311,234
-3,666
-1% -$113K
NJR icon
32
New Jersey Resources
NJR
$5.84B
$9.79M 1.28%
247,465
-3,900
-2% -$165K
POR icon
33
Portland General Electric
POR
$5.8B
$9.27M 1.21%
201,204
-2,050
-1% -$101K
TMO icon
34
Thermo Fisher Scientific
TMO
$213B
$9.08M 1.18%
17,991
-140
-0.8% -$66.1K
HON icon
35
Honeywell
HON
$77B
$8.27M 1.08%
39,977
-271
-0.7% -$57.3K
TMP icon
36
Tompkins Financial
TMP
$1.43B
$7.67M 1%
98,875
-1,500
-1% -$121K
HZNP
37
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.57M 0.86%
70,144
-2,183
-3% -$201K
ACM icon
38
Aecom
ACM
$9.3B
$6.29M 0.82%
99,301
-3,116
-3% -$204K
MRK icon
39
Merck
MRK
$322B
$6.18M 0.8%
79,423
-4,336
-5% -$323K
CACI icon
40
CACI
CACI
$11B
$5.58M 0.73%
21,875
-550
-2% -$142K
GVA icon
41
Granite Construction
GVA
$5.29B
$5.54M 0.72%
133,334
-1,500
-1% -$59.5K
AVGO icon
42
Broadcom
AVGO
$1.85T
$5.32M 0.69%
111,650
-3,500
-3% -$162K
NXST icon
43
Nexstar Media Group
NXST
$5.82B
$4.9M 0.64%
33,150
-400
-1% -$59.5K
VMW
44
DELISTED
VMware, Inc
VMW
$4.88M 0.64%
30,505
-450
-1% -$72K
LITE icon
45
Lumentum
LITE
$55.5B
$4.75M 0.62%
57,843
-1,205
-2% -$101K
IDA icon
46
Idacorp
IDA
$8.27B
$4.31M 0.56%
44,209
-300
-0.7% -$30.1K
ALB icon
47
Albemarle
ALB
$13.9B
$4.22M 0.55%
25,058
-450
-2% -$72.6K
WTS icon
48
Watts Water Technologies
WTS
$11.5B
$4.13M 0.54%
28,309
-1,650
-6% -$218K
EWS icon
49
iShares MSCI Singapore ETF
EWS
$1.04B
$4.12M 0.54%
177,350
-3,500
-2% -$82.6K
XRX icon
50
Xerox
XRX
$387M
$4.07M 0.53%
173,400
+75,300
+77% +$1.82M

Similar funds

John G. Ullman & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, John G. Ullman & Associates held 159 positions worth $768M, up 3% from $745M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q2 2021 filing shows 5 new, 19 increased, 83 reduced and 3 closed positions. Its largest new stake was Tutor Perini Cor: 269,100 shares worth $3.73M. The largest sale was ExxonMobil, an estimated $7.84M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • John G. Ullman & Associates's largest Q2 2021 buy was Tutor Perini Cor: 269,100 shares worth $3.73M.
  • John G. Ullman & Associates added most to Verizon in Q2 2021, an estimated $10.2M increase.
  • John G. Ullman & Associates's biggest Q2 2021 reduction was ExxonMobil, cutting an estimated $7.84M.
  • John G. Ullman & Associates fully exited Lifecore Biomedical in Q2 2021, selling an estimated $3.89M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $768M portfolio in Q2 2021.
  • John G. Ullman & Associates opened 5 new positions and closed 3 in Q2 2021.
  • John G. Ullman & Associates's portfolio value rose 3% quarter-over-quarter to $768M.

Based on John G. Ullman & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.